Delivery Order SPE2DB24D2101-SPE2DB25FKMTE
Award Date 7/24/25
Potential Completion Date 8/14/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $10,567.60 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Lynparza 150 mg, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and reflects a routine pharmaceutical procurement supporting military and federal healthcare operations. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,519.62 for 120 tablets of Lynparza 100 mg on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,543.70 for 60 tablets of Lynparza 100 mg on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a continuation of pharmaceutical supply services under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $10,499.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of LYNPARZA 150 mg, with a completion date of August 25, 2025. This non-set-aside competitive award leverages AmerisourceBergen's position as a critical pharmaceutical distributor within the federal medical supply chain. The order will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,519.62 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lynparza 100 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 30, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $10,519.62 to AmerisourceBergen Drug Corp for 120 tablets of Lynparza 100 mg on August 20, 2025, with an ultimate completion date of September 11, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order, this delivery falls under a larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,499.34 to AmerisourceBergen Drug Corp for 60 tablets of LYNPARZA 150 mg, a pharmaceutical product for oncology treatment. The contract, awarded on August 19, 2025, with an ultimate completion date of September 10, 2025, carries firm fixed pricing and represents a non-set-aside competitive award. Performance will be executed at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $21,135.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Lynparza 150 mg, a specialty pharmaceutical product. This non-set-aside competitive award, issued on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $10,519.62 to AmerisourceBergen Drug Corp for the supply of Lynparza 100 mg tablets (120 count) with a firm fixed price structure. This non-competitive delivery order, issued on July 21, 2025, is set to be completed by August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Lynparza is a specialized oncology medication used in cancer treatment, reflecting DLA's role in...
- The Defense Logistics Agency awarded a $21,039.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lynparza 100 mg tablets (120-count units) with an ultimate completion date of October 6, 2025. This non-set-aside contract was competitively awarded on September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...